Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000898432-26-000204·Amneal Pharmaceuticals, Inc.
Schedule 13D ownership disclosure
Amneal Pharmaceuticals Inc
Class A Common Stock, par value $0.01 · CUSIP: 03168L105
Event date: 2025-12-31
- Filing-level shares
- 16,904,263
- Percent of class
- 5.4%
- Patel DipanReported CIK 0001745437
Shares: 16,904,263 · Class: 5.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000898432-26-000204
- Form type
- SCHEDULE 13D/A
- Filer
- Amneal Pharmaceuticals, Inc.
- CIK
- CIK 1723128
- Filed
- Mar 26, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13D beneficial ownership